Citations

Mayo Clinic

Showing 10 of 108523 citations.

Symptom Representation and Treatment-Seeking Prior to Diagnosis of Atrial Fibrillation
McCabe, Pamela J. , Chamberlain, Alanna M. , Rhudy, Lori M. , DeVon, Holli A. , Rhudy, Lori, Chamberlain, Alanna M

Western Journal of Nursing Research | February 19, 2015 | Volume: 38 | Issue: 2 | Pages: 200-215

10.1177/0193945915570368 | PMID 25694177 Get It

Early treatment-seeking for symptoms of atrial fibrillation (AF) is critical to avert AF-related stroke and heart failure, but early treatment is hindered if symptoms are not accurately interpreted. The purpose of this research was to describe symptom representation and treatment-seeking responses prior to diagnosis of AF. For this descriptive study, 150 participants were surveyed to describe the type and temporality of symptoms, perceptions regarding the cause, seriousness, controllability of symptoms, and responses to symptoms prior to diagnosis. Participants’ mean age was 66.5 years, and 51% were female. Participants perceived symptoms as having nondisease-based causes, as not very serious, and as amenable to self-management. The majority took a wait and see response with 69% waiting more than 1 week after symptom onset to seek treatment. Lack of recognition of the seriousness of symptoms of AF and delayed treatment put patients at risk of poorer outcomes.
Hyaluronidase in Clinical Isolates ofPropionibacterium acnes
Tyner, Harmony L. , Patel, Robin , Tyner, Harmony , Patel, Robin

International Journal of Bacteriology | February 18, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-6

10.1155/2015/218918 | PMID 26904745 Get It

Objectives. We sought to describe the prevalence of a hyaluronidase gene and hyaluronidase production in 197 clinical isolates ofP. acnes; we assessed kinetics of hyaluronidase production in a subset of three isolates.Methods. The hyaluronidase gene was detected using polymerase chain reaction. Hyaluronidase production was detected by growing isolates on BHI agar containing 400 μg/mL hyaluronic acid and 1% albumin and flooding plates with 2 N glacial acetic acid to precipitate unbound hyaluronic acid, with a zone of clearing representing a positive phenotype. Hyaluronidase production kinetics were measured as a function of hyaluronic acid digestion over time in a liquid medium.Results. A hyaluronidase gene and hyaluronidase production were detected in 100 and 97% ofP. acnesisolates, respectively. Hyaluronidase production in liquid medium was detectable after 96 hours of growth.Conclusions. Hyaluronidase production is nearly universal amongP. acnesisolates. Three days appear to be required for significant hyaluronidase production in a liquid medium. Detection of hyaluronidase in tissue specimens may be a strategy to differentiateP. acnesinfection from colonization whenP. acnesis isolated from a clinical specimen.
Great Expectations: Pregnancy After Bariatric Surgery
Whited, M. Helen, Bersoux, Sophie , Jadoon-Khamash, Erum, Mayer, Anita P.

Journal of Women's Health | February 18, 2015 | Volume: 24 | Issue: 3 | Pages: 250-251

10.1089/jwh.2015.5196 | PMID 25692650 Get It

Long‐term risk of seizures and epilepsy in patients with posterior reversible encephalopathy syndrome
Datar, Sudhir , Singh, Tarun D. , Fugate, Jennifer E. , Hocker, Sara E. , Rabinstein, Alejandro A.

Epilepsia | February 18, 2015 | Volume: 56 | Issue: 4 | Pages: 564-568

10.1111/epi.12933 | PMID 25690439 Get It

SummaryObjectiveSeizures are common in patients with posterior reversible encephalopathy syndrome (PRES), which is reported in up to 70% of cases, and antiepileptic drugs (AEDs) are commonly prescribed. There is a paucity of data regarding the risk of subsequent seizures following resolution of PRES, and therefore the optimal duration of treatment with AEDs is currently unknown. The objective of this study was to identify the frequency of recurrent seizures and epilepsy following recovery from PRES.MethodsWe performed a retrospective review of consecutive adults diagnosed with PRES between 2000 and 2010.ResultsOne hundred twenty‐seven patients, median age 53 years (interquartile range [IQR] 37–64), were included in the analysis. The most common causes of PRES were hypertension (72%) and immunosuppression (20%). Renal failure was present in 47%. Eighty‐four patients (66%) had seizures at presentation (39 focal, 45 generalized), and 13 (15%) of them presented with status epilepticus. Median duration of follow‐up was 3.2 years (IQR 4 months to 6.9 years). Patients with seizures were treated with AEDs for a median of 3 months (IQR 2–7). Fifteen patients (12%) had provoked seizures during the follow‐up period; in eight (53%) patients seizures were caused by recurrent PRES. Only three patients had subsequent unprovoked seizures, one of whom was considered to have developed epilepsy.SignificanceWe conclude that unprovoked seizures and epilepsy are uncommon in patients who have recovered from PRES. Discontinuation of AEDs following resolution of PRES should be considered, provided there is adequate control of risk factors, and absence of factors that could substantially lower the seizure threshold.
Phenotype analysis impacts testing strategy in patients with Currarino syndrome
Čuturilo, Goran , Hodge, J.C., Runke, Cassandra , Thorland, Erik C., Al-Owain, Mohammad, Ellison, Jay W., Babovic‐Vuksanovic, Dusica

Clinical Genetics | February 18, 2015 | Volume: 89 | Issue: 1 | Pages: 109-114

10.1111/cge.12572 | PMID 25691298 Get It

Currarino syndrome (OMIM 175450) presents with sacral, anorectal, and intraspinal anomalies and presacral meningocele or teratoma. Autosomal dominant loss‐of‐function mutations in the MNX1 gene cause nearly all familial and 30% of sporadic cases. Less frequently, a complex phenotype of Currarino syndrome can be caused by microdeletions of 7q containing MNX1. Here, we report one familial and three sporadic cases of Currarino syndrome. To determine the most efficient genetic testing approach for these patients, we have compared results from MNX1 sequencing, chromosomal microarray, and performed a literature search with analysis of genotype–phenotype correlation. Based on the relationship between the type of mutation (intragenic MNX1 mutations vs 7q microdeletion) and the presence of intellectual disability, growth retardation, facial dysmorphism, and associated malformations, we propose a testing algorithm. Patients with the classic Currarino triad of malformations but normal growth, intellect, and facial appearance should have MNX1 sequencing first, and only in the event of a normal result should the clinician proceed with chromosomal microarray testing. In contrast, if growth delay and/or facial dysmorphy and/or intellectual disability are present, chromosomal microarray should be the first method of choice for genetic testing.
Improving drug delivery to primary and metastatic brain tumors: Strategies to overcome the blood–brain barrier
Parrish, KE, Sarkaria, JN, Elmquist, W. F.

Clinical Pharmacology & Therapeutics | February 18, 2015 | Volume: 97 | Issue: 4 | Pages: 336-346

10.1002/cpt.71 | PMID 25669487 Get It

Brain tumor diagnosis has an extremely poor prognosis, due in part to the blood–brain barrier (BBB) that prevents both early diagnosis and effective drug delivery. The infiltrative nature of primary brain tumors and the presence of micro‐metastases lead to tumor cells that reside behind an intact BBB. Recent genomic technologies have identified many genetic mutations present in glioma and other central nervous system (CNS) tumors, and this information has been instrumental in guiding the development of molecularly targeted therapies. However, the majority of these agents are unable to penetrate an intact BBB, leading to one mechanism by which the invasive brain tumor cells effectively escape treatment. The diagnosis and treatment of a brain tumor remains a serious challenge and new therapeutic agents that either penetrate the BBB or disrupt mechanisms that limit brain penetration, such as endothelial efflux transporters or tight junctions, are required in order to improve patient outcomes in this devastating disease.
Digoxin, hypercalcaemia, and cardiac conduction
Gerber, Thomas C., Hayes, David L. , Reeder, Guy S., Vella, Adrian

Postgraduate Medical Journal | February 18, 2015 | Volume: 75 | Issue: 887 | Pages: 554-556

10.1136/pgmj.75.887.554 | PMID 10616693 Get It

SummaryThe cardiac effects of hypercalcaemia are usually manifest as a shortening of the QT-interval. Hypercalcaemia is infrequently associated with a clinically manifest arrhythmia. However, concomitant therapy with digoxin or underlying cardiac disease can potentiate the arrhythmogenic effects of hypercalcaemia, leading to a symptomatic rhythm disorder. We describe a symptomatic arrhythmia, which developed in a patient with hypercalcaemia secondary to squamous cell carcinoma of the bronchus. The patient was on digoxin therapy at the time. The arrhythmia did not recur after discontinuation of digoxin therapy and correction of the hypercalcaemia. Because of its effect on cardiac conduction, hypercalcaemia should be considered in the evaluation of any patient with an unexplained bradyarrhythmia. Conversely, patients with hypercalcaemia should discontinue digoxin therapy and be evaluated for the presence of rhythm disorders while receiving appropriate treatment for hypercalcaemia.
β-Catenin in dendritic cells exerts opposite functions in cross-priming and maintenance of CD8 + T cells through regulation of IL-10
Fu, Chunmei, Liang, Xinjun , Cui, Weiguo , Ober-Blöbaum, Julia L., Vazzana, Joseph, Shrikant, Protul, Lee, Kelvin P. , Clausen, Björn E. , Jiang, Aimin , Shrikant, Protul A, Mellman, Ira , Cui, Weiguo

Proceedings of the National Academy of Sciences | February 17, 2015 | Volume: 112 | Issue: 9 | Pages: 2823-2828

10.1073/pnas.1414167112 | PMID 25730849 Get It

Significance While CD8 + T cells are essential for antitumor immunity, tumors often evade CD8 + T cell surveillance by immunosuppression. Recent study has shown that tumor-induced β-catenin activation in DCs suppresses CD8 + T cell immunity by inhibiting cross-priming, suggesting that activation of β-catenin in DCs might be a key mechanism tumors use to achieve immunosuppression. This report identified mTOR/IL-10 signaling as a previously unidentified mechanism for β-catenin–dependent inhibition of cross-priming. Surprisingly, our study also revealed that β-catenin in DCs was required for CD8 + T cell maintenance post-clonal expansion, suggesting that β-catenin exerts opposite functions during different stages of CD8 + T cell responses. Based on these findings, we have demonstrated selectively manipulating β-catenin signaling as a feasible strategy to improve DC vaccine efficacy.
A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Stegeman, Shane, Amankwah, Ernest K. , Klein, Kerenaftali, Kim, Donghwa , Lin, Hui‐Yi , Permuth‐Wey, Jennifer, Sellers, Thomas A. , Srinivasan, Srilakshmi , Eeles, Rosalind A. , Easton, Doug , Olama, Ali Amin Al , Benlloch, Sara, Muir, Kenneth , Wiklund, Fredrik, Grönberg, Henrik , Haiman, Christopher A. , Schleutker, Johanna , Nordestgaard, Børge G. , Travis, Ruth C. , Neal, David E. , Stanford, Janet L. , Blot, William J. , Thibodeau, Stephen N. , Maier, Christiane, Kibel, Adam S. , Brenner, Hermann , Kaneva, Radka , Teixeira, Manuel R. , BioResource, Australian Prostate Cancer, Clements, Judith A. , Batra, Jyotsna , Wahlfors, Tiina , Leongamornlert, Daniel , Southey, Melissa C. , Schumacher, Fredrick R. , Henrique, Rui , Hamdy, Freddie C. , Donovan, Jenny , Pashayan, Nora , Weischer, Maren , Saunders, Edward J. , Mitev, Vanio , Maia, Sofia , Tilley, Wayne D. , Thibodeau, Stephen, O’Mara, Tracy A. , Kote‐Jarai, Zsofia , Giles, Graham G. , Pharoah, Paul D.P. , Khaw, Kay‐Tee , Cybulski, Cezary , Cannon‐Albright, Lisa , BioResource, Australian Prostate Cancer, Spurdle, Amanda B. , Park, Jong Y. , Paulo, Paula , Teixeira, Manuel R , Eeles, Rosalind A , Southey, Melissa C , Donovan, Jenny L , Muir, Kenneth , Schleutker, Johanna , Travis, Ruth C , Pashayan, Nora , Lin, Hui-Yi , Brenner, Hermann , Pinto, Pedro , Batra, Jyotsna , Clements, Judith

Cancer Discovery | February 17, 2015 | Volume: 5 | Issue: 4 | Pages: 368-379

10.1158/2159-8290.cd-14-1057 | PMID 25691096 Get It

Abstract Prostate cancer is the second most common malignancy among men worldwide. Genome-wide association studies have identified 100 risk variants for prostate cancer, which can explain approximately 33% of the familial risk of the disease. We hypothesized that a comprehensive analysis of genetic variations found within the 3′ untranslated region of genes predicted to affect miRNA binding (miRSNP) can identify additional prostate cancer risk variants. We investigated the association between 2,169 miRSNPs and prostate cancer risk in a large-scale analysis of 22,301 cases and 22,320 controls of European ancestry from 23 participating studies. Twenty-two miRSNPs were associated (P < 2.3 × 10−5) with risk of prostate cancer, 10 of which were within 7 genes previously not mapped by GWAS studies. Further, using miRNA mimics and reporter gene assays, we showed that miR-3162-5p has specific affinity for the KLK3 rs1058205 miRSNP T-allele, whereas miR-370 has greater affinity for the VAMP8 rs1010 miRSNP A-allele, validating their functional role. Significance: Findings from this large association study suggest that a focus on miRSNPs, including functional evaluation, can identify candidate risk loci below currently accepted statistical levels of genome-wide significance. Studies of miRNAs and their interactions with SNPs could provide further insights into the mechanisms of prostate cancer risk. Cancer Discov; 5(4); 368–79. ©2015 AACR. See related commentary by Yousef, p. 351 This article is highlighted in the In This Issue feature, p. 333
Plasma membrane Ca 2+ -ATPases can shape the pattern of Ca 2+ transients induced by store-operated Ca 2+ entry
Caride, Ariel J. , Bajzer, Željko, Offord, Chetan P., Padányi, Rita , Hegedüs, Luca , Varga, Karolina , Strehler, Emanuel E. , Enyedi, Ágnes , Pászty, Katalin

Science Signaling | February 17, 2015 | Volume: 8 | Issue: 364 | Pages: No page available

10.1126/scisignal.2005672 | PMID 25690014 Get It

Plasma membrane calcium pumps differentially affect the pattern of calcium signals.